Theriva Biologics, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Theriva Biologics, Inc. (TOVX) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.19% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-08
- Theriva Biologics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 2.19%, a 56.43% increase year-over-year.
- Theriva Biologics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 1.40%.
- Theriva Biologics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.41%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | 2.19% 10-Q · filed 2018-05-08 | ||||
| 2017-12-31 | 1.86% 10-Q · filed 2018-05-08 | ||||
| 2017-12-26 | 2.42% 10-Q · filed 2018-05-08 | ||||
| 2017-09-30 | 1.48% 10-Q · filed 2017-11-01 | ||||
| 2017-06-30 | 1.43% 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | 1.40% 10-Q · filed 2017-05-04 | ||||
| 2016-12-31 | 1.41% 10-K · filed 2018-02-22 | ||||
| 2016-11-18 | 1.39% 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |